HIGH TIDE INC (HITI) Fundamental Analysis & Valuation

NASDAQ:HITICA42981E4013

Current stock price

2.26 USD
-0.05 (-2.16%)
Last:

This HITI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. HITI Profitability Analysis

1.1 Basic Checks

  • In the past year HITI has reported negative net income.
  • HITI had a positive operating cash flow in the past year.
  • In the past 5 years HITI always reported negative net income.
  • Of the past 5 years HITI 4 years had a positive operating cash flow.
HITI Yearly Net Income VS EBIT VS OCF VS FCFHITI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M -60M

1.2 Ratios

  • HITI's Return On Assets of -13.49% is fine compared to the rest of the industry. HITI outperforms 64.25% of its industry peers.
  • With a Return On Equity value of -52.89%, HITI perfoms like the industry average, outperforming 49.22% of the companies in the same industry.
  • HITI has a better Return On Invested Capital (6.12%) than 82.90% of its industry peers.
Industry RankSector Rank
ROA -13.49%
ROE -52.89%
ROIC 6.12%
ROA(3y)-11.05%
ROA(5y)-14.75%
ROE(3y)-30.28%
ROE(5y)-32.2%
ROIC(3y)N/A
ROIC(5y)N/A
HITI Yearly ROA, ROE, ROICHITI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200 -250

1.3 Margins

  • Looking at the Operating Margin, with a value of 3.11%, HITI is in the better half of the industry, outperforming 78.76% of the companies in the same industry.
  • In the last couple of years the Operating Margin of HITI has grown nicely.
  • With a Gross Margin value of 26.05%, HITI perfoms like the industry average, outperforming 55.96% of the companies in the same industry.
  • HITI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.11%
PM (TTM) N/A
GM 26.05%
OM growth 3YN/A
OM growth 5Y10.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y-6.82%
HITI Yearly Profit, Operating, Gross MarginsHITI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60 -80

3

2. HITI Health Analysis

2.1 Basic Checks

  • HITI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for HITI has been increased compared to 1 year ago.
  • HITI has more shares outstanding than it did 5 years ago.
  • HITI has a worse debt/assets ratio than last year.
HITI Yearly Shares OutstandingHITI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
HITI Yearly Total Debt VS Total AssetsHITI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • HITI has an Altman-Z score of 1.77. This is a bad value and indicates that HITI is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of HITI (1.77) is better than 61.14% of its industry peers.
  • HITI has a debt to FCF ratio of 5.97. This is a neutral value as HITI would need 5.97 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 5.97, HITI belongs to the best of the industry, outperforming 82.38% of the companies in the same industry.
  • A Debt/Equity ratio of 0.97 indicates that HITI is somewhat dependend on debt financing.
  • HITI has a Debt to Equity ratio of 0.97. This is in the lower half of the industry: HITI underperforms 70.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 5.97
Altman-Z 1.77
ROIC/WACC0.68
WACC9%
HITI Yearly LT Debt VS Equity VS FCFHITI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 1.43 indicates that HITI should not have too much problems paying its short term obligations.
  • HITI's Current ratio of 1.43 is on the low side compared to the rest of the industry. HITI is outperformed by 72.02% of its industry peers.
  • HITI has a Quick Ratio of 1.43. This is a bad value and indicates that HITI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HITI has a worse Quick ratio (0.72) than 83.94% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 0.72
HITI Yearly Current Assets VS Current LiabilitesHITI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

6

3. HITI Growth Analysis

3.1 Past

  • The earnings per share for HITI have decreased strongly by -519.69% in the last year.
  • Looking at the last year, HITI shows a quite strong growth in Revenue. The Revenue has grown by 17.36% in the last year.
  • Measured over the past years, HITI shows a very strong growth in Revenue. The Revenue has been growing by 48.14% on average per year.
EPS 1Y (TTM)-519.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.64%
Revenue 1Y (TTM)17.36%
Revenue growth 3Y18.51%
Revenue growth 5Y48.14%
Sales Q2Q%23.57%

3.2 Future

  • HITI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.45% yearly.
  • The Revenue is expected to grow by 13.19% on average over the next years. This is quite good.
EPS Next Y122.26%
EPS Next 2Y58.17%
EPS Next 3Y39.81%
EPS Next 5Y30.45%
Revenue Next Year26.26%
Revenue Next 2Y21.38%
Revenue Next 3Y16.85%
Revenue Next 5Y13.19%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HITI Yearly Revenue VS EstimatesHITI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
HITI Yearly EPS VS EstimatesHITI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1

6

4. HITI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HITI. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 10.05 indicates a reasonable valuation of HITI.
  • HITI's Price/Forward Earnings ratio is rather cheap when compared to the industry. HITI is cheaper than 87.56% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.19. HITI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 10.05
HITI Price Earnings VS Forward Price EarningsHITI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HITI is valued cheaper than 91.19% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, HITI is valued cheaper than 86.53% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.59
EV/EBITDA 7.73
HITI Per share dataHITI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as HITI's earnings are expected to grow with 39.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.17%
EPS Next 3Y39.81%

0

5. HITI Dividend Analysis

5.1 Amount

  • No dividends for HITI!.
Industry RankSector Rank
Dividend Yield 0%

HITI Fundamentals: All Metrics, Ratios and Statistics

HIGH TIDE INC

NASDAQ:HITI (3/27/2026, 8:23:35 PM)

2.26

-0.05 (-2.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-17
Earnings (Next)06-15
Inst Owners13.93%
Inst Owner Change-0.2%
Ins Owners8.84%
Ins Owner ChangeN/A
Market Cap198.65M
Revenue(TTM)629.85M
Net Income(TTM)-46.73M
Analysts80
Price Target5.32 (135.4%)
Short Float %0.49%
Short Ratio0.85
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.63%
Min Revenue beat(2)0.29%
Max Revenue beat(2)0.98%
Revenue beat(4)3
Avg Revenue beat(4)0.22%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)1.09%
Revenue beat(8)6
Avg Revenue beat(8)0.25%
Revenue beat(12)9
Avg Revenue beat(12)0.49%
Revenue beat(16)13
Avg Revenue beat(16)7.31%
PT rev (1m)-0.37%
PT rev (3m)-0.21%
EPS NQ rev (1m)-75%
EPS NQ rev (3m)-87.5%
EPS NY rev (1m)3.54%
EPS NY rev (3m)1.99%
Revenue NQ rev (1m)-0.8%
Revenue NQ rev (3m)-1.45%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-2.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.05
P/S 0.44
P/FCF 14.59
P/OCF 9.46
P/B 3.11
P/tB N/A
EV/EBITDA 7.73
EPS(TTM)-0.42
EYN/A
EPS(NY)0.22
Fwd EY9.95%
FCF(TTM)0.15
FCFY6.85%
OCF(TTM)0.24
OCFY10.57%
SpS5.18
BVpS0.73
TBVpS-0.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -13.49%
ROE -52.89%
ROCE 7.75%
ROIC 6.12%
ROICexc 7.18%
ROICexgc 17.59%
OM 3.11%
PM (TTM) N/A
GM 26.05%
FCFM 2.99%
ROA(3y)-11.05%
ROA(5y)-14.75%
ROE(3y)-30.28%
ROE(5y)-32.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y8.85%
ROICexc growth 3YN/A
ROICexc growth 5Y9.97%
OM growth 3YN/A
OM growth 5Y10.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y-6.82%
F-Score2
Asset Turnover1.82
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 5.97
Debt/EBITDA 1.86
Cap/Depr 38.53%
Cap/Sales 1.62%
Interest Coverage 2.48
Cash Conversion 63.05%
Profit Quality N/A
Current Ratio 1.43
Quick Ratio 0.72
Altman-Z 1.77
F-Score2
WACC9%
ROIC/WACC0.68
Cap/Depr(3y)33.59%
Cap/Depr(5y)35.25%
Cap/Sales(3y)1.64%
Cap/Sales(5y)2.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-519.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.64%
EPS Next Y122.26%
EPS Next 2Y58.17%
EPS Next 3Y39.81%
EPS Next 5Y30.45%
Revenue 1Y (TTM)17.36%
Revenue growth 3Y18.51%
Revenue growth 5Y48.14%
Sales Q2Q%23.57%
Revenue Next Year26.26%
Revenue Next 2Y21.38%
Revenue Next 3Y16.85%
Revenue Next 5Y13.19%
EBIT growth 1Y51.49%
EBIT growth 3YN/A
EBIT growth 5Y64.03%
EBIT Next Year690.23%
EBIT Next 3Y135.81%
EBIT Next 5Y77.27%
FCF growth 1Y-0.6%
FCF growth 3YN/A
FCF growth 5Y16.8%
OCF growth 1Y14.26%
OCF growth 3Y74.46%
OCF growth 5Y21.95%

HIGH TIDE INC / HITI Fundamental Analysis FAQ

What is the fundamental rating for HITI stock?

ChartMill assigns a fundamental rating of 4 / 10 to HITI.


What is the valuation status for HITI stock?

ChartMill assigns a valuation rating of 6 / 10 to HIGH TIDE INC (HITI). This can be considered as Fairly Valued.


Can you provide the profitability details for HIGH TIDE INC?

HIGH TIDE INC (HITI) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for HITI stock?

The Earnings per Share (EPS) of HIGH TIDE INC (HITI) is expected to grow by 122.26% in the next year.